Prokineticin1 and pregnancy

Annales d'Endocrinologie

Volumn 77, Issue 2, 2016, Pages 101-104

  Alfaidy, Nadia ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b DIF   (France)

Author keywords

EG VEGF; IUGR; Parturition; Placenta; Preeclampsia; Prokineticin

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; FETUS CIRCULATION; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY DISORDER; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; ANIMAL; FEMALE; GENETICS; MOUSE; PHYSIOLOGY; REPRODUCTION;

ANIMALS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MICE; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 84965160451     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2016.04.014     Document Type: Article

References (42)

1. LeCouter J., Ferrara N. EG-VEGF and the concept of tissue-specific angiogenic growth factors. Semin Cell Dev Biol 2002, 13:3-8.
2. Li M., et al. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 2001, 59:692-698.
3. Ngan E.S., et al. Prokineticin-1 (Prok-1) works coordinately with glial cell line-derived neurotrophic factor (GDNF) to mediate proliferation and differentiation of enteric neural crest cells. Biochim Biophys Acta 2008, 1783:467-478.
4. Cheng M.Y., et al. Prokineticin 2 is an endangering mediator of cerebral ischemic injury. Proc Natl Acad Sci U S A 2012, 109:5475-5480.
5. Hu W.P., et al. Impaired pain sensation in mice lacking prokineticin 2. Mol Pain 2006, 2:35.
6. LeCouter J., et al. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci U S A 2004, 101:16813-16818.
7. Battersby S., et al. Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab 2004, 89:2463-2469.
8. Brouillet S., et al. Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci 2012, 69:1537-1550.
9. Brouillet S., et al. EG-VEGF: a key endocrine factor in placental development. Trends Endocrinol Metab 2012, 23:501-508.
10. Hoffmann P., Feige J.J., Alfaidy N. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta 2007, 28:1049-1058.
11. Hoffmann P., et al. Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med 2009, 13:2224-2235.
12. Hoffmann P., Feige J.J., Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 2006, 147:1675-1684.
13. LeCouter J., et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001, 412:877-884.
14. Petrik J.J., et al. Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine. Endocrine 2009, 36:281-290.
15. Ajonuma L.C., et al. EG-VEGF concentrations may predict OHSS. Fertil Steril 2011, 95:e37-e38. [author reply].
16. Gao M.Z., et al. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2011, 95:673-678.
17. Xu L.Z., et al. Effect of high ovarian response on the expression of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in peri-implantation endometrium in IVF women. Int J Clin Exp Pathol 2015, 8:8902-8911.
18. Lin D.C., et al. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 2002, 277:19276-19280.
19. Masuda Y., et al. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun 2002, 293:396-402.
20. Soga T., et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 2002, 1579:173-179.
21. Chen J., et al. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1. Mol Pharmacol 2005, 67:2070-2076.
22. Alfaidy N., et al. The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis. Biomed Res Int 2014, 2014:451906.
23. Brouillet S., et al. Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 2010, 21:2832-2843.
24. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004, 25:581-611.
25. Fraser H.M., et al. Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 2005, 90:427-434.
26. Guilini C., et al. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. Am J Physiol Heart Circ Physiol 2010, 298:H844-H852.
27. Kisliouk T., et al. Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J Clin Endocrinol Metab 2003, 88:3700-3707.
28. LeCouter J., et al. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci U S A 2003, 100:2685-2690.
29. Evans J., et al. Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor. FASEB J 2009, 23:2165-2175.
30. Evans J., et al. Prokineticin 1 signaling and gene regulation in early human pregnancy. Endocrinology 2008, 149:2877-2887.
31. Karaer A., et al. Prokineticin 1 and leukemia inhibitory factor mRNA expression in the endometrium of women with idiopathic recurrent pregnancy loss. Fertil Steril 2014, 102:1091e1-1095e1.
32. Macdonald L.J., et al. Prokineticin 1 induces Dickkopf 1 expression and regulates cell proliferation and decidualization in the human endometrium. Mol Hum Reprod 2011, 17:626-636.
33. Shaw J.L., et al. Cotinine exposure increases fallopian tube PROKR1 expression via nicotinic AChRalpha-7: a potential mechanism explaining the link between smoking and tubal ectopic pregnancy. Am J Pathol 2010, 177:2509-2515.
34. Shaw J.L., et al. Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFkappaB activation resulting in a microenvironment predisposed to ectopic pregnancy. Am J Pathol 2011, 178:253-260.
35. Salker M., et al. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One 2010, 5:pe10287.
36. Su M.T., et al. Gene-gene interactions and risk of recurrent miscarriages in carriers of endocrine gland-derived vascular endothelial growth factor and prokineticin receptor polymorphisms. Fertil Steril 2014, 102:1071e3-1077e3.
37. Su M.T., et al. Prokineticin receptor variants (PKR1-I379V and PKR2-V331M) are protective genotypes in human early pregnancy. Reproduction 2013, 146:63-73.
38. Su M.T., et al. Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss. Hum Reprod 2010, 25:2923-2930.
39. Dunand C., et al. Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition. Biol Reprod 2014, 91:p73.
40. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
41. Sergent F., Hoffmann P., Brouillet S., Garnier V., Salomon A., Murthi P., Benharouga M., Feige J.J., Alfaidy N. Sustained EG-VEGF levels beyond the first-trimester of pregnancy display phenotypic and functional changes associated with the pathogenesis of pregnancy-induced hypertension. Hypertension. 2016, 68.
42. Levine R.J., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.